Polymeric drugs carrying glycolipids have been designed as target macromolecules for the
treatment of brain tumours. A methacrylate derivative of oleyl 2-acetamido-2-deoxy-α-d …

An octyl N-acetylglucosaminide derivative with a pentaerythritol chain at position 6 has been
synthesized and evaluated as an inhibitor of neural tumor growth. The glycoside inhibited …

Graft copolymers of poly (ϵ‐caprolactone)(PCL) on poly (dimethylacrylamide)(PDMAm),
poly (methylmethacrylate)(PMMA), or on copolymers of poly (DMAm‐co‐MMA) have been …

Glioblastoma multiforme (GBM) is the most common, most aggressive and lethal of brain
cancers. Patients with GBM exhibit a survival between 12 and 15 months. Unfortunately …

The treatment for glioblastoma multiforme (GBM) has not changed for more than 20 years
while the prognosis for the patients is still poor and most of them survive less than 1 year …

Glioblastoma (GBM) is the most common and deadly primary malignant brain tumor. Current
therapies are insufficient, and survival for individuals diagnosed with GBM is limited to a few …

Drug treatment of glioblastoma, the most aggressive and widespread form of brain cancer, is
complicated due to the difficulty of penetration of chemotherapeutic drugs through the blood …

1-O-Hexadecyl-2-O-methyl-3-O-(2'-amino-2'-deoxy-β-d-glucopyranosyl)-sn-glycerol (1) was
previously reported to show potent in vitro antitumor activity on a range of cancer cell lines …

Brain cancers, mainly high-grade gliomas/glioblastoma, are characterized by uncontrolled
proliferation and recurrence with an extremely poor prognosis. Despite various conventional …

The influence of the chain microstructure on release process of doxorubicin from polymeric
matrices was analyzed. Aliphatic polyester copolymers with optimal chain microstructure, ie …